BOLTE AXEL (See Remarks) reported 1 transaction at INOZYME PHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 7/3/2025ACC: 0000950170-25-094096
DirectorOfficer10% Owner· See Remarks
Since Jul 2020
-817.29K
Net shares
Net seller
$1.70M
Total sold
0
Open market trades
0B · 0S
3
Total transactions
817.29K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−423.93K
Price / share
$4.00
Trade value
$1.70M
% of position
New position
7/1/2025
423.93K→0.00
Total
Net shares
−423.93K
Net value
-$1.70M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/1/2025 | U · U | −423.93K | $4.00 | $1.70M | New position | 423.93K | 0.00 |
| Total | −423.93K | -$1.70M | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
234.18K shares
Shares
−234.18K
Strike price
2.02
Held after
0.00
Exercisable
—
7/1/2025
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
159.19K shares
Shares
−159.19K
Strike price
2.77
Held after
0.00
Exercisable
—
7/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock234.18K shares | 7/1/2025 | D · Disposition | −234.18K | 2.02 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock159.19K shares | 7/1/2025 | D · Disposition | −159.19K | 2.77 | — | 0.00 |